Interferon-α and survival in metastatic renal carcinoma: early results of a randomised controlled trial
- 1 January 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9146), 14-17
- https://doi.org/10.1016/s0140-6736(98)03544-2
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 1998
- Interferon Gamma-1b Compared with Placebo in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 1998
- Interferon‐alpha and survival in renal cell cancerBritish Journal of Urology, 1995
- On the development of the medical research council trial of α-interferon in metastatic renal carcinomaStatistics in Medicine, 1994
- Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom ChecklistBritish Journal of Cancer, 1990
- Recombinant Leukocyte Interferon Alpha-2A and Medroxyprogesterone in Advanced Renal Cell Carcinoma: A Randomized TrialActa Oncologica, 1990
- Stratification of risk factors in renal cell carcinomaCancer, 1983